Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate.
Durlach
J
J
SDRM, Hôpital Saint-Vincent-de-Paul, Paris, France.
Bac
P
P
Bara
M
M
Guiet-Bara
A
A
D000818:Animals; D002547:Cerebral Palsy / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007275:Injections, Intravenous; D008274:Magnesium / Q000009:adverse effects* / Q000633:toxicity; D017616:Magnesium Compounds / Q000008:administration & dosage / Q000633:toxicity; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D011247:Pregnancy; D015149:Tocolytic Agents / Q000009:adverse effects*
D017616:Magnesium Compounds; D015149:Tocolytic Agents; D008278:Magnesium Sulfate; D008274:Magnesium